Search

Author/Creator Lewicki, John

1. Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. (4th November 2015)

Authors:
Srivastava, Minu; Murriel, Christopher; Yun, Rui; Mayes, Erin; Jie, Hyun-Bae; Axelrod, Fumiko; Xie, Ming-Hong; Bentley, Trevor; Cancilla, Belinda; Tam, Raymond; O'Young, Gilbert; Kapoun, Ann; Lewicki, John; Hoey, Tim; Gurney, Austin; Inkyung, Park Angie
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Issue 2 (December 2015)

Authors:
Srivastava, Minu; Murriel, Christopher; Yun, Rui; Mayes, Erin; Jie, Hyun-Bae; Axelrod, Fumiko; Xie, Ming-Hong; Bentley, Trevor; Cancilla, Belinda; Tam, Raymond; O'Young, Gilbert; Kapoun, Ann; Lewicki, John; Hoey, Tim; Gurney, Austin; Inkyung, Park
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search